Jubilant Pharmaceuticals is an API manufacturer based in United States. It appears in 264 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, MPA (SE) and INFARMED (PT).
| Molecule | Regulators | Docs |
|---|---|---|
| Dalfampridine | SFDA (Saudi Arabia) | 1 |
| Levocetirizine Dihydrochloride | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 109 | None |
| MPA (SE) | 91 | None |
| INFARMED (PT) | 27 | None |
| DKMA (DK) | 20 | None |
| AEMPS (ES) | 16 | None |
| BRELA (TZ) | 1 | None |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Jubilant Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.